|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||||||||
  BJOG: An International Journal of Obstetrics & GynaecologyVolume 114 Issue 9, Pages 1055 - 1064 Published Online: 12 Jun 2007 Journal compilation © 2010 RCOG Published on behalf of the Royal College of Obstetricians and Gynaecologists
Abstract | References | Full Text: HTML, PDF (Size: 120K) | Related Articles | Citation Tracking  Prevalence and predictors of antidepressant use in a cohort of pregnant women Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation Copyright 2007 The Authors Journal compilation KEYWORDS Antidepressants • dosage • predictors • pregnancy • prevalence • switch ABSTRACTObjective (1) To determine the prevalence of antidepressant utilisation before, during, and after pregnancy, (2) to determine switches, dosages, and classes of antidepressant used during pregnancy, and (3) to identify factors associated with their use at the beginning and at the end of pregnancy. Design Retrospective longitudinal cohort. Setting The 'Medication and Pregnancy' cohort was used for this study. This cohort was built by the linkage of three administrative databases (Régie de l'Assurance Maladie du Québec [RAMQ], Med-Écho, and l'Institut de la Statistique du Québec). Population All pregnancies occuring in Quebec between January 1 1998 and December 31 2002. Methods Date of entry in the cohort was the first day of gestation. To be eligible for this study, women had to be (1) 15–45 years old at cohort entry and (2) covered by the RAMQ drug plan for at least 12 months before, during, and at least 12 months after pregnancy. Antidepressant users were defined as those receiving at least one antidepressant before, during, or after pregnancy, depending on the time period analysed. Logistic regression models were used to identify factors associated with receiving an antidepressant either at the beginning or at the end of pregnancy. Main outcome measures To determine the prevalence and predictors associated with the use of antidepressants. Results A total of 97 680 women met inclusion criteria. The prevalence rates significantly declined during the first trimester compared with before pregnancy (3.7 versus 6.6%, P < 0.01). During pregnancy, antidepressants were used under the recommended daily dosage 7.7% of the time, and 4.7% of women switched to another class of antidepressant. Factors significantly associated with antidepressant utilisation on the first day of gestation (P < 0.05) were older maternal age, being on welfare, and calendar year; receiving at least six different types of medications other than antidepressants, having at least two different prescribers, having at least three visits to the physician, and having at least one diagnosis of depression in the year before pregnancy also increased the odds of having an antidepressant. Similar predictors were found at the end of pregnancy. Conclusions Our findings indicate that antidepressant utilisation declines once pregnancy is diagnosed. Accepted 27 November 2006. Published OnlineEarly 12 June 2007. | 
|
